Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.

Geertrude H Struijk, Robert C Minnee, Sven D Koch, Aeilko H Zwinderman, Karlijn A M I van Donselaar-van der Pant, Mirza M Idu, Ineke J M ten Berge, Frederike J Bemelman

Journal: Kidney international 2011;78(9):934-40

PMID: 20703211

Free Full Text on Elsevier Science View on PubMed

Abstract

While the guidelines for vaccination in renal transplant recipients recommend the use of pneumococcal polysaccharide (PPS) and tetanus toxoid (TT), their efficacy in immunocompromised renal transplant recipients is not known. Here we tested the effect of everolimus on immune responses after vaccination by measuring the capacity of 36 stable renal transplant recipients to mount cellular and humoral responses after vaccination. Twelve patients in each treatment arm received immunosuppressive therapy consisting of prednisolone (P) plus cyclosporine (CsA), mycophenolate sodium (MPA), or everolimus. Patients were vaccinated with the T-cell-dependent antigens immunocyanin and TT, and the T-cell-independent PPS. Treatment with CsA partially inhibited and MPA completely abolished the capacity to mount a primary humoral response, whereas everolimus left this largely intact. Recall responses were inhibited by MPA only. All drug combinations inhibited cellular responses against TT. In patients treated with MPA, B-cell numbers were severely reduced. Thus, combined with P, treatment with MPA completely disturbed primary and secondary humoral responses. Everolimus or CsA allowed the boosting of T-cell-dependent and -independent secondary humoral responses. Treatment with everolimus allowed a primary response.

Address: Renal Transplant Unit, Department of Nephrology, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. [email protected]

DOI: 10.1038/ki.2010.269

Link outs

Free resources

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0085...

Medical:

https://medlineplus.gov/kidneytransplantation.html

MeSH Terms: Adjuvants, Immunologic, Adult, Aged, B-Lymphocytes, Cells, Cultured, Cyclosporine, Cytokines, Drug Therapy, Combination, Everolimus, Female, Hemocyanins, Humans, Immunity, Cellular, Immunity, Humoral, Immunoglobulin G, Immunosuppressive Agents, Kidney Transplantation, Male, Middle Aged, Mycophenolic Acid, Netherlands, Pneumococcal Vaccines, Prednisolone, Prospective Studies, Sirolimus, T-Lymphocytes, Tetanus Toxoid, Time Factors, Treatment Outcome